Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial.

cagrilintide/semaglutide (CagriSema) - Novo Nordisk

zalfermin (NNC0194-0499) - Novo Nordisk

BL-9010 - BioLineRx

cagrilintide (AM833) - Novo Nordisk

http://www.ncbi.nlm.nih.gov/pubmed/42456707

Ahsan Shoeb; Anna Bille Larsen; Birgitte Andersen; Eric Lawitz; Jacob George; Jesper Ole Clausen; Laurent Castera; Lise Lotte Gluud; Rohit Loomba; Sven Francque

Jul 16, 2026